Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonalcoholic Fatty Liver (NAFL)”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Not applicableUnknownNCT03801577
What this trial is testing

Hepaxa Management of Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon Alcoholic Fatty LiverNASH - Nonalcoholic Steatohepatitis
BASF AS 50
Not applicableLooking for participantsNCT07068191
What this trial is testing

Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)HepatomegalyNonalcoholic Fatty Liver (NAFL)+5 more
Phenomen Pharma 90
Testing effectiveness (Phase 2)Study completedNCT04704063
What this trial is testing

Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL)

Who this might be right for
Hepatic SteatosisNAFLD
Yuen Kah Hay 170
Not applicableUnknownNCT04682600
What this trial is testing

The Sonic Incytes Liver Incytes System, Evaluation of Liver Fibrosis and Steatosis Versus MRE and MRI PDFF

Who this might be right for
Non-Alcoholic Fatty Liver Disease (NAFLD)Non-Alcoholic Steatohepatitis (NASH)Liver Fibroses+1 more
Sonic Incytes 164
Not applicableStudy completedNCT04823676
What this trial is testing

Efficacy and Safety of a Probiotic Composition as Adjunct in MAFL Management

Who this might be right for
Non Alcoholic Fatty Liver
AB Biotics, SA 100
Not applicableStudy completedNCT03678727
What this trial is testing

Effects of Exercise on VLDL-TG Metabolism

Who this might be right for
NAFLD - Nonalcoholic Fatty Liver DiseaseNASH - Nonalcoholic Steatohepatitis
University of Aarhus 19
Not applicableStudy completedNCT04292977
What this trial is testing

Splanchnic and Systemic VLDL-TG and FFA Balance

Who this might be right for
NAFLDNASH - Nonalcoholic Steatohepatitis
University of Aarhus 17
Not applicableUnknownNCT05523024
What this trial is testing

Effect of Probiotics or Berberine in Hepatic Steatosis Markers, Cardiometabolic and Microbiotic Profile in NAFL.

Who this might be right for
Non Alcoholic Fatty LiverObesity
Poznan University of Medical Sciences 140
Not applicableUnknownNCT06032650
What this trial is testing

Calisthenics Versus High Intensity Interval Training in NAFL

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Cairo University 60
Not applicableUnknownNCT05128253
What this trial is testing

Characterization of the Platelet Inflammatory Response in NAFL and NASH

Who this might be right for
NASH - Nonalcoholic SteatohepatitisNAFLD
Stefania Basili 44
Not applicableUnknownNCT05908006
What this trial is testing

Validation Study of the Velacur System in Comparison to MRE & MRI-PDFF in Patients With (Suspected) Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
GI Alliance 100
Not applicableStudy completedNCT02923804
What this trial is testing

Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients

Who this might be right for
Non Alcoholic Fatty Liver
Pronova BioPharma 172
Not applicableStudy completedNCT04616664
What this trial is testing

Diagnostic Accuracy of the "LLIFT", a Novel Non-invasive Biomarker for the Diagnosis of Non Alcoholic Fatty Liver (NAFL) and SteatoHepatitis (NASH) in a Population With High Risk of Metabolic Syndrome"

Who this might be right for
ObesityNASH - Nonalcoholic Steatohepatitis
University Hospital, Lille 158
Testing effectiveness (Phase 2)Ended earlyNCT03953456
What this trial is testing

Study to Evaluate the Effect of Elafibranor on Hepatic Lipid Composition in Subjects With Nonalcoholic Fatty Liver (NAFL)

Who this might be right for
Non-Alcoholic Fatty Liver
Genfit 17
Testing effectiveness (Phase 2)Study completedNCT04198805
What this trial is testing

Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-Alcoholic Fatty LiverNon-Alcoholic Steatohepatitis
Naga P. Chalasani 205